Innorna: Engineering Targeted mRNA-LNPs to Advance In Vivo Immunotherapy

  • From Protein Replacement to In Vivo Immunotherapy: Expanding the Reach of LNPs
  • Translational Insights from Preclinical and clinical
  • Enabling Extrahepatic Targeting and Non-IV Delivery Across LNP Designs

NEW DATA